Furthermore, the CD123 expression level was lower on BPDCN than on pDC from pDC-AML and healthy donors, and lower on normal CD34+ progenitors than on blasts from pDC-AML and AML without pDC excess [3]. This evidence concerns the gene CD34 and acute myeloid leukemia.